Gefitinib CAS No.184475-35-2 / Cat No.EBD446
Gefitinib(ZD1839)
N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
Gefitinib
Iressa
AKOS91371
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine
ZD1839
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-
Gefitinib(TINIBS)
Gefitinib,Iressa,ZD1839
GefitinibBase
Geftinib
4-Quinazoli
Properties
-
Appearance:
light-yellow crystalline powder
-
Density:
1.322 g/cm3
-
Melting point:
119-1200C
-
Boiling point:
586.8 °C at 760 mmHg
-
Flashing point:
308.7 °C
Safety Information
-
Symbol:
-
Signal words:
Warning -
Hazard statements:
H302 Harmful if swallowed.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
-
Precautionary statements:
P301+P312+P330 IF SWALLOWED:Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
NMR Spectrum
Prediction： 1H NMR (400 MHz, d6-DMSO) O 9.44 (5, 1H), 8.50 (5, 1H), 8.12 (dd, J= 6.9, 2.7 Hz,1H), 7.80 (m, 2H), 7.44 (t, 1H), 7.20 (5, 1H), 4.18 (t, J= 6.7 Hz, 2H), 3.94 (5, 3H), 3.59(t, J = 4.4 Hz, 4H), 2.49 (t, J = 6.9 Hz, 2H), 2.41 (bs, 4H), 2.00 (m, 2H).
1H NMR
13C NMR
